This phenomenon, which is known as the 'somatopause', has led to recombinant human GH being widely promoted and abused as an antiageing drug, despite lack of evidence of efficacy
In clinical trials, Retatrutide showed significant promise, with early results suggesting it could offer greater weight loss than existing options like Wegovy and Zepbound
Percentage Achieving Weight Loss Thresholds Key Finding: Both medications get most patients past 20% loss
Rybelsus (semaglutide) tablets, for oral use
The Danish drugmaker plans to launch Extensior, a lower-cost authorised version of Ozempic, in South Africa on 27 July through a partnership with Swiss healthcare company Acino
The blue light issue is real, but it's also the mental stimulation your phone keeps your brain in problem-solving mode when it needs to be winding down